Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Autolomous to Provide Digital Solutions to Center for Breakthrough Medicines to Streamline and Automate Manufacturing of Cell & Gene Therapies
Autolomous LTD, the market-leading developer of critical manufacturing management systems for Cell and Gene Therapies (CGT), has announced […]
Neutron Therapeutics Announces Successful Generation of a Neutron Beam for BNCT at Shonan Kamakura General Hospital in Japan
Neutron Therapeutics (NT), a targeted radiation oncology therapy company developing a comprehensive clinical solution for […]
Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors
Relmada Therapeutics, a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today […]
NHS Cuts Waiting Lists As A&E Departments Busier Than Ever Before
The NHS waiting list has fallen for the first time since the start of the […]
Oramed Announces Top-line Results from Phase 3 Trial of ORMD-0801 for the Treatment of Type 2 Diabetes
Oramed Pharmaceuticals, a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, […]
Novotech Acquires European CRO EastHORN, Strengthens Global Operations
Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory […]
Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]
Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe
Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]
Hexaware Technologies Expands its Global Life Sciences and Healthcare IT Consulting and Technology Practice
Hexaware Technologies, one of the world’s leading global IT consulting, technology and digital solutions provider, […]
Medivir Partner Infex Therapeutics Receives FDA QIDP Designation
Medivir AB has announced that its partner Infex Therapeutics, a leading anti-infectives specialist, has been […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more